HB 1460, the Health System Protection Act, requires health care entities (like hospitals and clinics) and certain investors (such as private equity firms) to obtain pre-approval from Pennsylvania's Department of Health and Attorney General before completing major transactions. This applies to sales of assets worth $10 million or more, ownership changes, or large financial distributions that could affect competition, costs, or access to care. The law prohibits transactions deemed "against the public interest," such as those reducing competition, raising prices, or limiting services in rural or low-income areas. Health care entities must either file a notification with a waiting period or get written approval before proceeding.
HB 507, the Baby Food Protection Act, requires Pennsylvania's Department of Health to test all baby food batches for toxic heavy metals like lead, arsenic, cadmium, and mercury. It sets strict limits: baby food cannot exceed 10 parts per billion (ppb) of arsenic, 5 ppb for lead or cadmium, or 2 ppb for mercury. All tested baby food must display labels showing the exact metal levels found in the batch. The bill also directs the Department to adopt lower federal limits if set by the FDA and expires if federal law matches its requirements.
This bill establishes legal protections for music therapy by requiring anyone who identifies as a music therapist to hold a valid certification from the Certification Board for Music Therapists. It prohibits unlicensed individuals from claiming to be music therapists, using specific credentials like "MT-BC," or implying they are qualified to provide clinical music therapy services. While the law allows professionals to use music in their general work, it strictly forbids them from representing themselves as certified music therapists without the proper credential. Violations of these rules are classified as third-degree misdemeanors and are also treated as unfair trade practices under state consumer protection laws.
This bill amends Pennsylvania's Insurance Company Law to update definitions and provisions related to health insurance coverage. It clarifies how certain government health programs are defined for insurance policies, specifically regarding prescription drug coverage and continuation of coverage for employees who lose their jobs. The legislation also updates the legal definition of a hospital to include facilities operating alcoholism or drug addiction treatment programs and establishes a Long-Term Care Partnership Program to help individuals manage future long-term care costs.
HB 2427 amends Pennsylvania's Insurance Company Law to regulate how insurers cover drugs for stage four, advanced metastatic cancer. The bill prohibits insurance policies from requiring patients to fail a different medication or prove a history of failure before approving coverage for a new drug, provided the drug is FDA-approved and aligns with current clinical best practices. This legislation also repeals the previous Fair Access to Cancer Treatment Law while ensuring that all existing rules, contracts, and decisions made under that law remain in effect.
HB 836 prohibits Pennsylvania from interfering with the use of medically appropriate assisted reproductive technology (ART), such as in vitro fertilization (IVF), ensuring individuals can access these services without state restrictions. The bill defines ART to include specific fertility procedures and requires that any new state laws must comply with this protection unless explicitly exempted by the legislature. It takes effect immediately, providing direct safeguards for individuals seeking ART services and healthcare providers offering them.
This bill creates a new chapter in Pennsylvania law to regulate medical devices by banning specific toxic chemicals known as ortho-phthalates, with a primary focus on DEHP. The legislation targets manufacturers of intravenous solution containers and tubing, which currently use these chemicals to make plastic flexible. By prohibiting the intentional addition of these substances, the bill aims to prevent the chemicals from leaching into patient fluids and reducing the effectiveness of cancer treatments. The law is based on findings that these compounds can act as endocrine disruptors, potentially harming reproductive health and contributing to drug resistance in cancer cells.
This Pennsylvania House Resolution designates the week of September 28 through October 4, 2026, as "Frontotemporal Degeneration Awareness Week" to highlight a rare and incurable brain disease. The measure directly affects residents of Pennsylvania who may be living with or caring for individuals diagnosed with frontotemporal degeneration, a condition that impacts behavior, speech, and movement. By officially recognizing this specific time period, the resolution aims to increase public understanding of the disease's symptoms and the need for better diagnosis and support. This is a commemorative action intended to draw attention to the condition rather than to enact new laws or funding.
HB 911 provides health benefits for surviving family members of Pennsylvania law enforcement officers who die or become disabled in the line of duty. It guarantees surviving spouses lifetime full health coverage and dependent children full coverage until age 26 (if not covered by another employer plan). Municipalities must assist with claims processing, and benefits end at age 65. The bill applies to all full-time law enforcement officers and their families, including those widowed before the law's effective date. It codifies existing benefit standards under Pennsylvania law without creating new programs.
This Pennsylvania bill designates June 2026 as Aphasia Awareness Month to promote public understanding of aphasia, a language disorder often caused by strokes or brain injuries. The resolution aims to highlight the condition's impact on individuals and their communities while encouraging better diagnosis and treatment. It does not create new laws or funding but serves as a symbolic gesture to raise awareness within the state.
